Neogenomics (NEO) Free Cash Flow Growth (1y) (2011 - 2026)
Neogenomics (NEO) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -117.95% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 126.04% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 2.94% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 24.06% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -20.33% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 87.85% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 15.26% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 20.67% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -30.93% |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | 55.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.96% |
| Dec 31, 2025 | -50.94% |
| Sep 30, 2025 | 136.70% |
| Jun 30, 2025 | 1,620.76% |
| Mar 31, 2025 | 5.31% |
| Dec 31, 2024 | 114.77% |
| Sep 30, 2024 | -113.76% |
| Jun 30, 2024 | 104.57% |
| Mar 31, 2024 | -127.17% |
| Dec 31, 2023 | -15.13% |
| Sep 30, 2023 | 146.81% |
| Jun 30, 2023 | 34.79% |
| Mar 31, 2023 | 62.78% |
| Dec 31, 2022 | 166.06% |
| Sep 30, 2022 | -6.03% |
| Jun 30, 2022 | 25.21% |
| Mar 31, 2022 | -28,982.95% |
| Dec 31, 2021 | -247.26% |
| Sep 30, 2021 | -56.02% |
| Jun 30, 2021 | -989.28% |